Sign in to our online system or register for a new account to submit a letter of intent.
Neurodegenerative diseases of aging are among the least understood and most undertreated diseases today. Diseases such as Alzheimer’s and Parkinson’s are placing a large and increasing burden on society. If ignored, the social and economic costs of managing these diseases will rise significantly within a generation. Meeting these challenges requires pioneering approaches to accelerating treatments.
The Early Phase Clinical Trials: Canada program was created to provide funding support for clinical trials and clinical trial sub-studies with excellent preliminary data.
Continuing for 2020:
Goal: To provide funding to support clinical trials and/or clinical trial sub-studies that could accelerate the development of therapeutics for neurodegenerative diseases of aging.
Funding: A maximum of $1,500,000 per project over up to 4 years. If you are requesting a budget between $1.5 to $2 million per project, please contact Cristina Tang (email@example.com) prior to applying.
Eligible Principal Applicants must meet all of the criteria below:
Co-applicants and Collaborators must be at the post-doctoral level or above, and can be working outside Canada.
Applicants may appear in any role on any number of projects.
Projects must meet these conditions to be eligible:
Please refer to the What We Fund page for Institute definitions of neurodegenerative diseases of aging, translational research, therapeutic, tool, complementary approaches, and clinical trials.
The Institute welcomes additional inquiries about this program, including whether a potential idea is in scope. Please contact Cristina Tang at firstname.lastname@example.org or 416-967-7823.
There are two stages to the application process:
An application requires the submission of a Letter of Intent which will be reviewed by our scientific review committee. Applicants with high potential projects will then be invited to submit a Proposal. Instructions for submitting the Proposal will be forwarded to those invited.
Applicants can expect to receive the outcome of their LOI application within ~2 months of submission.
Program Details (Updated Jan 22, 2020)
Request for Applications (RFA) (Updated Jan 22, 2020)
Letter of Intent sample (Updated Jan 22, 2020)